At Marshall BioResources, our mission is to be the premier source of purpose bred animals and related services for the preclinical development of human drugs, biologics and other therapies, as well as for the clinical development of companion animal pharmaceuticals.
We have been a proud member of the biomedical research community since we began raising laboratory animals in 1939. Our animals have contributed to medical advancements for almost 80 years, and this is why our dedication to quality, consistency and the highest standards of animal welfare is so important.
We offer several animal models, including Marshall Beagles®, Influenza-free Marshall Ferrets®, Antibody Profile Defined/Specific Pathogen Free (APD/SPF) Marshall Beagles® and Cats, Interferon Receptor Negative Knockout Mice (AG129 & A129), Guinea Pigs negative for GpCMV & PI-3, and we are the exclusive provider of Gottingen Minipigs® in North America. We also offer a wide range of services and related products, as well as clinical study services for the development of companion animal vaccines and drugs.